Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Costs of long-term complications in type 2 diabetes patients in Germany. Results of the CODE-2 Study].

Andreas Liebl1, Andrea Spannheimer, Ursula Reitberger

  • 1Fachklinik Diabetes und Stoffwechselzentrum, Bad Heilbrunn. dr.liebl@t-online.de

Medizinische Klinik (Munich, Germany : 1983)
|December 20, 2002
PubMed
Summary

Managing diabetes type 2 complications like ulcers, amputations, and strokes incurs significant costs. Early prevention of these diabetes-related issues is crucial for reducing overall healthcare expenditure and improving patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy and Safety of Intensifying Once-Weekly Insulin Icodec Treatment With Once-Weekly Semaglutide in Adults With Type 2 Diabetes: A Single-Arm, Open-Label, Treat-to-Target, Phase 3b Trial (ONWARDS 8).

Diabetes, obesity & metabolism·2026
Same author

Glycaemic Control According to the Final Insulin Dose Using an Innovative Fixed-Dose Titration of Weekly Insulin Efsitora in Insulin-Naïve Type 2 Diabetes.

Diabetes, obesity & metabolism·2026
Same author

Higher Derived Time in Range With IDegLira Versus Insulin Glargine U100 in People With Type 2 Diabetes.

Journal of diabetes science and technology·2023
Same author

Transitioning from basal-bolus or premix insulin therapy to a combination of basal insulin and glucagon-like peptide-1 receptor agonist in people with type 2 diabetes.

Diabetic medicine : a journal of the British Diabetic Association·2022
Same author

Higher Rates of Persistence and Adherence in Patients with Type 2 Diabetes Initiating Once-Weekly vs Daily Injectable Glucagon-Like Peptide-1 Receptor Agonists in US Clinical Practice (STAY Study).

Diabetes therapy : research, treatment and education of diabetes and related disorders·2021
Same author

The relation between the intelligibility of irrelevant speech and cognitive performance-A revised model based on laboratory studies.

Indoor air·2020

Area of Science:

  • Diabetology
  • Health Economics
  • Public Health

Context:

  • The study analyzed data from the German arm of the Costs of Diabetes in Europe (CODE-2) study.
  • Retrospective data collection involved medical files of 809 patients and interviews with 135 primary care physicians.
  • Results were extrapolated to the broader German type 2 diabetes population.

Purpose:

  • To determine the economic burden of specific diabetes-related complications in Germany.
  • To analyze the influence of micro- and macrovascular complications on total healthcare costs.
  • To quantify the costs associated with lower extremity ulcers, amputations, and stroke in type 2 diabetes patients.

Summary:

  • Approximately half of type 2 diabetes patients experience severe comorbidities, with over 56% having more than one.

Related Experiment Videos

  • Patients with macro- or microvascular complications incur costs 2.5 to 4.1 times higher than average insured individuals.
  • Specific complication costs: ulcer (EURO 7,537), amputation (EURO 10,796), and stroke (EURO 7,147) annually.

    • Impact:

    • This analysis highlights the substantial financial impact of managing diabetes complications.
    • Emphasizes the need for early complication prevention to reduce overall healthcare costs.
    • Suggests that preventive measures, despite potential initial cost increases, can lead to significant long-term savings.